Brief: John Lunger, of Adaptimmune, Joins Genocea Biosciences' Board of Directors
07/03/2022 21:22
March 7 (Reuters) - Genocea Biosciences Inc GNCA.O :
* JOHN LUNGER, OF ADAPTIMMUNE, JOINS GENOCEA BIOSCIENCES'
BOARD OF
DIRECTORS
Source text for Eikon: ID:nGNX8vJq1Y
Further company coverage: GNCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc